How real-world data can facilitate the development of precision medicine treatment in psychiatry

First published: January 2024 DOI: https://doi.org/10.1016/j.biopsych.2024.01.001

Laymen's summary: 

This article examines how collecting and analysing extensive, real-world data, including genetic information, can improve precision medicine in psychiatry. It stresses the importance of using advanced tools to categorise patients and predict treatment outcomes, and the potential of a platform to monitor patient progress. The challenges in treating serious mental illnesses and the role of precision medicine in enhancing treatment are discussed. The paper also highlights the need to combine data from various sources, including genomics, to refine predictions about treatment effectiveness.

The article addresses the use of large-scale datasets, like electronic health records individual patient data (IPD) meta-analysis, in psychiatry. It explores the potential and challenges of using genomic research and artificial intelligence in mental health treatment, including predicting psychosis and ethical issues in psychiatric precision. The discussion includes the ethical, legal, and social aspects of genetic research, stressing the need for informed consent and data protection.

The authors advocate integrating diverse data sources and predictive algorithms into a platform for tailored treatments in psychiatry, and they provide a guide for research and clinical practice in this field, including tackling biases and stigma in mental health.

Access the article here. 

Published Jan. 11, 2024 2:18 PM - Last modified Feb. 6, 2024 7:57 AM